Literature DB >> 32835874

Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.

Rannakoe J Lehloenya1, Thuraya Isaacs2, Tonderai Nyika3, Ashar Dhana3, Lauren Knight3, Simon Veenstra4, Jonny Peter5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32835874      PMCID： PMC7874517          DOI： 10.1016/j.jaip.2020.08.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  8 in total

1.  Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.

Authors:  Julia A Curtis; Laura-Catherine Christensen; Allison R Paine; Grace Collins Brummer; Erika M Summers; Amalia L Cochran; Marta J Petersen; Christopher M Hull
Journal:  J Am Acad Dermatol       Date:  2016-02       Impact factor: 11.527

Review 2.  Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens-Johnson syndrome.

Authors:  Alla Y Hynes; Crysanthi Kafkala; Yassine J Daoud; C Stephen Foster
Journal:  Int Ophthalmol Clin       Date:  2005

Review 3.  Genomic and nongenomic effects of glucocorticoids.

Authors:  Cindy Stahn; Frank Buttgereit
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-02

Review 4.  Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.

Authors:  Tetsuo Shiohara; Yoshiko Mizukawa
Journal:  Allergol Int       Date:  2019-04-16       Impact factor: 5.836

Review 5.  Immune regulation by glucocorticoids.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Nat Rev Immunol       Date:  2017-02-13       Impact factor: 53.106

6.  U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Authors:  D Creamer; S A Walsh; P Dziewulski; L S Exton; H Y Lee; J K G Dart; J Setterfield; C B Bunker; M R Ardern-Jones; K M T Watson; G A E Wong; M Philippidou; A Vercueil; R V Martin; G Williams; M Shah; D Brown; P Williams; M F Mohd Mustapa; C H Smith
Journal:  Br J Dermatol       Date:  2016-06       Impact factor: 9.302

7.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Authors:  Robert S Stern; Sherrie J Divito
Journal:  J Invest Dermatol       Date:  2017-05       Impact factor: 8.551

Review 8.  Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.

Authors:  Lalit Kumar Gupta; Abhay Mani Martin; Nidheesh Agarwal; Paschal D'Souza; Sudip Das; Rajesh Kumar; Sushil Pande; Nilay Kanti Das; Muthuvel Kumaresan; Piyush Kumar; Anubhav Garg; Saurabh Singh
Journal:  Indian J Dermatol Venereol Leprol       Date:  2016 Nov-Dec       Impact factor: 2.545
  8 in total
  4 in total

Review 1.  Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics.

Authors:  Ellen Minaldi; Elizabeth J Phillips; Allison Norton
Journal:  Clin Rev Allergy Immunol       Date:  2021-11-12       Impact factor: 8.667

2.  Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

Authors:  Natsumi Hama; Riichiro Abe; Andrew Gibson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

Review 3.  Updates and Insights in the Diagnosis and Management of DRESS Syndrome.

Authors:  Elisa Maria Schunkert; Sherrie Jill Divito
Journal:  Curr Dermatol Rep       Date:  2021-11-09

4.  Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature.

Authors:  Jing-Yi Wu; Kai Kang; Jing Yi; Bin Yang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.